Patents
Patents for C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
04/2006
04/05/2006CN1754880A Process for preparing 2-iminopyrrolidine derivatives
04/05/2006CN1754877A Anthracene derivative and organic electroluminescence device using the derivative
04/05/2006CN1754876A Process for preparing high purity letrozole
04/05/2006CN1249051C Muscarinic agonists
04/04/2006US7022860 2-(1-isopropoxycarbonyloxy-2-methylpropyl)-7,8-dimethoxy-4(5H),10 -dioxo-2H-1,2,3-triazolo(4,5-c)(1)benzazepine, for example; chemical intermediates, synthesis using relatively inexpensive reagents
04/04/2006US7022736 Enzyme inhibitors
04/04/2006CA2294624C Cationic monobenzene nitrophenylenediamines, their use in dying keratin fibres, dyeing compositions containing them and dyeing processes
03/2006
03/30/2006WO2005047899A3 Use of the lipoxin receptor, fprl1, as a tool for identifying compounds effective in the treatment of pain and inflammation
03/30/2006US20060069132 Azolecarboxamide herbicides
03/30/2006US20060069067 Combination of an aromatase inhibitor with a bisphosphonate
03/29/2006EP1638964A1 Novel compounds that modulate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions
03/29/2006EP1638947A2 Triazole derivatives as inhibitors of 11-beta hydroxysteroid dehydrogenase-1
03/29/2006EP1638944A1 Tachykinin receptor antagonists
03/29/2006EP1638923A2 Fungicidal phenoxyphenylhydrazine derivatives
03/29/2006EP1303270B1 Method for treating cryptorchidism
03/29/2006CN1247549C Benzotriazole compound and use thereof
03/29/2006CN1247548C Cesium triazoleamide compounds and their preparation and use
03/28/2006US7019144 E.g. 1-(4-methanesulfonylphenyl)-5-phenyl-3-trifluoromethyl-1H-1,2,4-triazole; side effect reduction; antipyretics; analgesics; non-steroidal antiinflamatory agents; cyclooxygenase 2 inhibitors; anticarcinogenic agents; Alzheimer's disease; antiulcer agents; gastrointestinal disorders
03/28/2006US7019053 Stabilizer mixtures
03/28/2006US7019003 Bactericides
03/28/2006US7018570 produced by melt-mixing a benzotriazole and a resin stabilizer; has excellent compatibility with synthetic resins and provides a stabilized synthetic resin molding
03/28/2006CA2120374C 9-[(substituted glycyl) amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines
03/23/2006WO2006030805A1 Triazole derivative or salt thereof
03/23/2006WO2006030285A1 New 1,2,4-triazole-3-carboxamide derivatives
03/23/2006WO2006029634A2 Pharmaceutical compositions containing insulin and insulinotropic peptide
03/23/2006WO2005082892A3 Triazole compounds as antibacterial agents and pharmaceutical compositions containing them
03/23/2006US20060063843 Compounds for the treatment of inflammatory disorders
03/23/2006CA2580409A1 Triazole derivative or salt thereof
03/23/2006CA2579799A1 Benzoyl-substituted serine amides
03/22/2006EP1635824A2 5-membered heterocycle-based p-38 inhibitors
03/22/2006EP1030847B1 Method for producing triazolinthion derivatives
03/22/2006CN1749256A Novel oxazolidone derivative, its preparing method and use
03/21/2006US7015331 A compound selected from the group consisting of 1,2,3-benzotriazol-2-yl-L-alanine, 5-carboxy-1,2,3-benzotriazol-2-yl-L-alanine, and 5-carboxy-1,2,3-benzotriazol-1-yl-L-alanine.
03/21/2006CA2158691C Process for the preparation of alkoxytriazolinones
03/16/2006WO2006027170A1 6-phenyl-7-amino-triazolopyrimidines, methods for the production thereof, the use thereof for controlling pathogenic fungi, and agents containing the same
03/16/2006US20060058302 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases; example compound: 2-Chloro-5-(3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl)-N-(2-ethyl-hexyl)-benzamide
03/16/2006US20060058288 Severe sepsis preventive therapeutic agent
03/16/2006CA2579004A1 Mercaptoamides as histone deacetylase inhibitors
03/16/2006CA2578789A1 Substituted heterocyclic compounds and uses thereof
03/16/2006CA2577041A1 6-phenyl-7-amino-triazolopyrimidines, methods for the production thereof, the use thereof for controlling pathogenic fungi, and agents containing the same
03/15/2006EP1633701A1 Benzamide nitrile derivatives
03/15/2006EP1289992B1 New crystalline form of a triazolo(4,5-d)pyrimidine compound
03/14/2006US7012146 Modulators of all three classes of calcium channel blocker subtypes (Small, Intermediate and Big conductance K channel (SK, IK and BK)) comprising malonate esters and nitriles; respiratory, brain, cardiovascular, urogenital disorders
03/14/2006US7012075 Cathepsin cysteine protease inhibitors
03/14/2006US7012071 such as 4-(4-(2-Fluorobenzyloxy)phenyl)-4-oxobutyric acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
03/09/2006WO2006024523A1 Phthalamide derivatives for use as insecticides
03/09/2006WO2005063239A9 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders
03/09/2006US20060052596 preventing or treating cancer or an inflammatory disorder by administering to a subject in need thereof one or more substituted heterocyclic compounds
03/09/2006US20060052589 Colorant compounds containing copolymerizable vinyl groups
03/09/2006US20060052469 Colorant compounds containing copolymerizable vinyl groups
03/09/2006US20060052445 Diarylsulfones as 5-HT2A antagonists
03/09/2006US20060052355 reacting a chloro contaiing triaryl- or trialkyl-orthoester with a sulfonic acid salt of semicarbazide in an organic solvent, adding a brine solution to the concentrated reaction mixture,cooling the mixture to form a solid product, acidification with aqueous acid
03/09/2006DE10231627B4 Heterozyklisch substituierte Benzoylharnstoffe und ihre Verwendung als Arzneimittel Heterocyclic unsubstituted benzoyl ureas and their use as a medicament
03/08/2006EP1632477A1 Benzamide derivative or salt thereof
03/08/2006EP1198454B1 Mutilin derivatives and their use as antibacterials
03/08/2006CN1244575C Sulfonyl alkylamido hydroxyethylamino sulfonamide retroviral protease inhibitors
03/07/2006US7009056 Glaucoma; multiple sclerosis
03/07/2006US7009025 An optical lens containing 2-(2-hydroxy-4-octyloxyphenyl)-benzotriazole dispersed in a polymer formed by polymerizing a thiourethane monomer and a hard film on a surface of the lens produced by curing a coating liquid containing an organosilicon
03/02/2006WO2006021806A1 Arylsulphonylstilbene derivatives for treatment of insomnia and related conditions
03/02/2006WO2006021805A1 Diarylsulfones as 5-ht2a antagonists
03/02/2006WO2006000544A3 Electroluminescent metal complexes with triazoles and benzotriazoles
03/02/2006US20060047116 Such as N-methyl(1-{2-[(1R,5S)-3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl}-2,3-dihydro-1H-inden-1-yl)methanamine; chemokine receptor antagonists; prevention or treatment of a human T-cell leukemia/lymphoma virus infection
03/02/2006CA2578370A1 Triazolobenzodiazepines and their use as vasopressin antagonists
03/02/2006CA2577837A1 Diarylsulfones as 5-ht2a antagonists
03/01/2006CN1243735C 2-lminopyrrolidine derivatives
02/2006
02/28/2006US7005526 Thioether derivatives
02/28/2006US7005433 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
02/23/2006US20060041132 Novel triazolo pyrimidine compounds
02/23/2006DE102005037484A1 Preparation of pure anastrozole useful to treat e.g. breast cancer involves dissolving 3,5-bis(2-cyanoprop-2-yl)benzylbromide in organic solvent other than carbon tetrachloride, then reacting with sodium thiazole or triazole, and purifying
02/23/2006DE102004039065A1 New N-substituted 1-benzyl-1H-(1,2,3)-triazole-4-carboxamides, are dopamine and alpha-1 adrenergic receptor ligands useful for treating diseases of the urinary tract, vascular system or CNS
02/22/2006EP1626962A1 Benzamide inhibitors of the p2x7 receptor
02/22/2006EP1456210B1 Pyrazolyl-substituted triazoloquinoxalines
02/22/2006CN1738805A N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) -1-piperidincarboxamid-derivatives and related compounds use as CGRP-antagonists for treating a headache
02/22/2006CN1738615A Diaminotriazoles useful as inhibitors of protein kinases
02/22/2006CN1242996C Method for synthesizing 1H-1, 2,3 triazole
02/21/2006US7001918 7-pyrrolyl tetracycline compounds and methods of use thereof
02/16/2006WO2005080317A3 Therapeutic amide derivatives
02/16/2006US20060035950 Novel processes for preparing substantially pure anastrozole
02/16/2006US20060035909 2,6,9-trisubstituted 8-azapurines such as 2-(4-aminocyclohexylamino)-6-benzylamino-9-isopropyl-8-azapurine, used as cyclin-dependent kinase inhibitors, in the treatment of skin disorders, viral infections, cancer, arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, gout
02/16/2006CA2575430A1 1,3-disubstituted heteroaryl nmda/nr2b antagonists
02/15/2006EP1019327B1 Method for eliminating a nitrogenated heterocyclic, or aromatic, compound in an effluent
02/15/2006CN1733740A Candle wax compositions stabilized with UV absorber-metal combinations
02/15/2006CN1733739A 3-nitro-1,2,4-triazole-5-ketone superfining process
02/15/2006CN1733725A Process for preparing 2-iminopyrrolidine derivatives
02/14/2006US6998423 Sulfonyl-amino or carbonyl-amino derivatives; osteoporosis bone disorders; therapeutic drug or kits including anti-resorptive agents, anabolic agents;
02/14/2006US6998409 Drugs for treating chronic pain; stereoisomers; chemical synthesis from intermediates; nontoxic
02/14/2006US6998407 For prophylaxis and therapy of chronic or acute inflammatory or autoimmune diseases, those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease
02/09/2006WO2006014134A1 Novel piperidine derivative for the treatment of depression
02/09/2006WO2006013948A1 Triazole derivative
02/09/2006US20060030618 Vanilloid receptor ligands and their use in treatments
02/09/2006CA2576073A1 Novel piperidine derivative for the treatment of depression
02/08/2006EP1622870A2 Glutaminyl based dp iv-inhibitors
02/08/2006EP1318978B1 N-acylsulfonamide apoptosis promoters
02/08/2006CN1732161A 1,3-diamino-2-hydroxypropane pro-drug derivatives
02/08/2006CN1732160A 1,2,4-triazole derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
02/08/2006CN1732146A Cycloalkyl inhibitors of potassium channel function
02/07/2006US6995273 1H-pyrazolo[1,5-b]-1,2,4-triazole compound, coupler and silver halide color photographic light-sensitive material
02/07/2006US6995182 1-sulfonyl pyrrolidine derivatives
02/02/2006WO2005115996B1 Sulfamic acid ester compounds useful in the inhibition of seroid sulphatase activity and aromatase activity
02/02/2006US20060025547 Styrene polymers and phenol-triazole type complexes, catalysts, and processes for polymerizing
1 ... 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 ... 178